http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16239436

Outgoing Links

Predicate Object
contentType Journal Article
issn 1471-2407
issueIdentifier 1
pageRange 1187-
publicationName BMC Cancer
startingPage 1187
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f23caef5255c9b17901c68ad776bb11b
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3e4744add3dd892ca502da964e45afd2
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_110f89d6b52f81afe3533cd6d64d2425
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_98856f8de67b10afd6b05ae34fbc9b9c
bibliographicCitation Tian Y, Wu J, Chagas C, Du Y, Lyu H, He Y, Qi S, Peng Y, Hu J. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC). BMC Cancer. 2018 Nov 29;18(1):1187. PMID: 30497429; PMCID: PMC6267780.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2964896348c906d35ccebbb49ce0e7d2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89b0d51f41f6fe8f284d5a72a0da7a56
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3476bc7457a39fdd22c274c9e7d3d6e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58a6b37d7c6521b0c9e8102380463049
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e24a79a16419ca420266656428c64392
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2eb6b1fb4e54b4cbbd04652df6da9006
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a09370e18c91cb5c512c9e035be725c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88dcd9bac3a6a62ad6ea9f41636f572c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2bddf2d8c01f00979b8627612a9f4b78
date 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/30497429
https://pubmed.ncbi.nlm.nih.gov/PMC6267780
https://doi.org/10.1186/s12885-018-5072-4
isPartOf https://portal.issn.org/resource/ISSN/1471-2407
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
https://www.crossref.org/
title CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
discusses http://id.nlm.nih.gov/mesh/M0462870
http://id.nlm.nih.gov/mesh/M0022149
http://id.nlm.nih.gov/mesh/M0485138
http://id.nlm.nih.gov/mesh/M0028143
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_95d926625e5919a35cb6aa367ba7b069
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8352
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fadc3c8509db129e10ef4cfccf6efc5d
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6a9a77d1592ff18f5315c1f5af6d7658
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID113130

Total number of triples: 42.